Windlas Biotech Limited Cash Flow-to-Debt Ratio
Windlas Biotech Limited cash flow-to-debt ratio. Windlas Biotech Limited (WINDLAS) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2023, meaning its operating cash flow of Rs66.60 Million could theoretically repay 0% of its total liabilities (Rs1.54 Billion) in one year. Check Windlas Biotech Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Windlas Biotech Limited (2018–2025)
Cash flow-to-debt ratio of Windlas Biotech Limited from 2018 to 2025. Historical debt coverage capacity for Windlas Biotech Limited across 8 annual periods. Check WINDLAS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Windlas Biotech Limited Cash Flow-to-Debt Ratio by Year (2018–2025)
Windlas Biotech Limited cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Windlas Biotech Limited. For the full cash flow conversion analysis, see Windlas Biotech Limited (WINDLAS) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | Rs681.87 Million | Rs2.55 Billion | ▼ -56.7% |
| 2024 | 0.62x | Rs1.09 Billion | Rs1.76 Billion | ▲ +28.5% |
| 2023 | 0.48x | Rs609.65 Million | Rs1.27 Billion | ▲ +407.2% |
| 2022 | 0.09x | Rs91.30 Million | Rs962.33 Million | ▼ -19.7% |
| 2021 | 0.12x | Rs114.54 Million | Rs970.04 Million | ▼ -39.2% |
| 2020 | 0.19x | Rs250.06 Million | Rs1.29 Billion | ▲ +8.8% |
| 2019 | 0.18x | Rs186.54 Million | Rs1.05 Billion | ▼ -0.6% |
| 2018 | 0.18x | Rs295.91 Million | Rs1.65 Billion | — |